quinidine has been researched along with 5-carboxamidotryptamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhamú, B; Berkels, R; Lauterbach, T; López-Rodríguez, ML; Marco, I; Martín-Fontecha, M; Ramos, JA; Valhondo, M; Vázquez-Villa, H | 1 |
| Bojarski, AJ; Cieślik, P; Handzlik, J; Hogendorf, A; Hogendorf, AS; Kieć-Kononowicz, K; Latacz, G; Lubelska, A; Wierońska, JM; Woźniak, M | 1 |
2 other study(ies) available for quinidine and 5-carboxamidotryptamine
| Article | Year |
|---|---|
New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
Topics: Analgesics; Animals; Binding, Competitive; Cyclic AMP; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; HeLa Cells; Heterocyclic Compounds, 2-Ring; Humans; Hydantoins; Kinetics; Ligands; Male; Mice; Models, Chemical; Molecular Structure; Pain; Pain Measurement; Piperazines; Pyridines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists | 2013 |
Search for a 5-CT alternative.
Topics: | 2018 |